Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysisAntonio D’Alessio, David J. Pinato, Julia Blanter et al.|The Lancet Oncology|2024Cited by 64
Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trialMarina Baretti, Nilofer S. Azad|Nature Communications|2024Cited by 35